Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy.

MLA

Kooijmans, Esmee C. M., et al. “Shrunken Pore Syndrome in Childhood Cancer Survivors Treated with Potentially Nephrotoxic Therapy.” Scandinavian Journal of Clinical & Laboratory Investigation, vol. 82, no. 7/8, Nov. 2022, pp. 541–48. EBSCOhost, https://doi.org/10.1080/00365513.2022.2129437.

APA

Kooijmans, E. C. M., van der Pal, H. J. H., Pilon, M. C. F., Pluijm, S. M. F., van der Heiden-van der Loo, M., Kremer, L. C. M., Bresters, D., van Dulmen-den Broeder, E., van den Heuvel-Eibrink, M. M., Loonen, J. J., Louwerens, M., Neggers, S. J. C., van Santen, H. M., Tissing, W. J. E., de Vries, A. C. H., Kaspers, G. J. L., Veening, M. A., & Bökenkamp, A. (2022). Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy. Scandinavian Journal of Clinical & Laboratory Investigation, 82(7/8), 541–548. https://doi.org/10.1080/00365513.2022.2129437

Chicago

Kooijmans, Esmee C. M., Helena J. H. van der Pal, Maxime C. F. Pilon, Saskia M. F. Pluijm, Margriet van der Heiden-van der Loo, Leontien C. M. Kremer, Dorine Bresters, et al. 2022. “Shrunken Pore Syndrome in Childhood Cancer Survivors Treated with Potentially Nephrotoxic Therapy.” Scandinavian Journal of Clinical & Laboratory Investigation 82 (7/8): 541–48. doi:10.1080/00365513.2022.2129437.